Caseware UK (AP4) 2023.0.135 2023.0.135 2024-08-312024-08-312023-09-01trueNo description of principal activitytruetrue11false 01128997 2023-09-01 2024-08-31 01128997 2022-09-01 2023-08-31 01128997 2024-08-31 01128997 2023-08-31 01128997 c:Director1 2023-09-01 2024-08-31 01128997 d:PatentsTrademarksLicencesConcessionsSimilar 2024-08-31 01128997 d:PatentsTrademarksLicencesConcessionsSimilar 2023-08-31 01128997 d:CurrentFinancialInstruments 2024-08-31 01128997 d:CurrentFinancialInstruments 2023-08-31 01128997 d:CurrentFinancialInstruments d:WithinOneYear 2024-08-31 01128997 d:CurrentFinancialInstruments d:WithinOneYear 2023-08-31 01128997 d:ShareCapital 2024-08-31 01128997 d:ShareCapital 2023-08-31 01128997 d:RetainedEarningsAccumulatedLosses 2024-08-31 01128997 d:RetainedEarningsAccumulatedLosses 2023-08-31 01128997 c:OrdinaryShareClass1 2023-09-01 2024-08-31 01128997 c:OrdinaryShareClass1 2024-08-31 01128997 c:OrdinaryShareClass1 2023-08-31 01128997 c:EntityHasNeverTraded 2023-09-01 2024-08-31 01128997 c:FRS102 2023-09-01 2024-08-31 01128997 c:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 01128997 c:FullAccounts 2023-09-01 2024-08-31 01128997 c:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 01128997 d:PatentsTrademarksLicencesConcessionsSimilar d:OwnedIntangibleAssets 2023-09-01 2024-08-31 01128997 e:PoundSterling 2023-09-01 2024-08-31 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 01128997









CYBERMED (U.K.) LIMITED







UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 31 AUGUST 2024

 
CYBERMED (U.K.) LIMITED
REGISTERED NUMBER: 01128997

BALANCE SHEET
AS AT 31 AUGUST 2024

2024
2023
Note
£
£

Fixed assets
  

Intangible assets
 5 
5,666
17,021

  
5,666
17,021

  

Creditors: amounts falling due within one year
 6 
(157,463)
(155,289)

Net current liabilities
  
 
 
(157,463)
 
 
(155,289)

Total assets less current liabilities
  
(151,797)
(138,268)

  

Net liabilities
  
(151,797)
(138,268)


Capital and reserves
  

Called up share capital 
 7 
100
100

Profit and loss account
  
(151,897)
(138,368)

  
(151,797)
(138,268)


Page 1

 
CYBERMED (U.K.) LIMITED
REGISTERED NUMBER: 01128997
    
BALANCE SHEET (CONTINUED)
AS AT 31 AUGUST 2024

For the year ended 31 August 2024 the Company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 24 October 2024.




M B Hughes
Director

The notes on pages 3 to 7 form part of these financial statements.

Page 2

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

1.


General information

The Company is a private company, limited by shares, incorporated and domiciled in England within the United Kingdom, registration number 01128997. The Company's registered office is 18 Hartford Close, Harborne, Birmingham, B17 8AU.
The financial statements are presented in sterling which is the functional currency of the company and the financial statements are rounded to the nearest £1.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

Cash flow
Under Financial Reporting Standard 102, the company is exempt from the requirement to prepare a cash flow statement on the grounds that it qualifies as a small company.

 
2.2

Going concern

The company has made losses and as such has net liabilities at the balance sheet date.  The main creditors of the company are the director and shareholders who intend to continue to support the company for the foreseeable future and the director therefore considers it appropriate to prepare the accounts on a going concern basis.

 
2.3

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 
2.4

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.5

Financial instruments

The Company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The Company has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the Company's Balance Sheet when the Company becomes
Page 3

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)


2.5
Financial instruments (continued)

party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Impairment of financial assets

Financial assets are assessed for indicators of impairment at each reporting date. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the Company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the
Page 4

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

2.Accounting policies (continued)


2.5
Financial instruments (continued)

effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Company's contractual obligations expire or are discharged or cancelled.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2023 - 1).


4.


Taxation

The company has trading tax losses of £147,042 (2023 - £133,513) available to offset against future trading profits.

Page 5

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

5.


Intangible assets




Patents

£



Cost


At 1 September 2023
50,996



At 31 August 2024

50,996



Amortisation


At 1 September 2023
33,975


Charge for the year on owned assets
11,355



At 31 August 2024

45,330



Net book value



At 31 August 2024
5,666



At 31 August 2023
17,021




6.


Creditors: Amounts falling due within one year

2024
2023
£
£

Other creditors
156,743
154,569

Accruals and deferred income
720
720

157,463
155,289



7.


Share capital

2024
2023
£
£
Allotted, called up and fully paid



100 (2023 - 100) Ordinary shares of £1.00 each
100
100


Page 6

 
CYBERMED (U.K.) LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 AUGUST 2024

8.


Related party transactions

As at 31 August 2024 amounts due to the director was £96,471 (2023 - £94,267) and amounts due to shareholders were £60,272 (2023 - £60,272).
All loans are interest free and repayable on demand.

 
Page 7